EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Novavax (NASDAQ:NVAX) Upgraded at Wall Street Zen - Stock Observer
Novavax (NASDAQ:NVAX) Upgraded to "Hold" at Wall Street Zen - Daily Political
Novavax (NASDAQ:NVAX) Rating Increased to Hold at Wall Street Zen
Novavax (NVAX) Laps the Stock Market: Here's Why
Novavax Highlights Sanofi, Pfizer Catalysts in Matrix-M Platform Pivot
Novavax (NASDAQ:NVAX) Trading Down 6.5% - Here's Why
Novavax, Inc. (NASDAQ:NVAX) Given Average Rating of "Hold" by Brokerages
Novavax Highlights Matrix-M Licensing Push, Oncology Ambitions at Cantor Conference
Vaccines Global Market Intelligence Report 2026-2035 Featuring Bio Farma, Emergent BioSolutions, GC Pharma, GlaxoSmithKline, Janssen, Merck, Novavax, Moderna, Pfizer, Sanofi Pasteur, and Valneva
Weekly Buzz: IONS, MIST, BIIB, AZN Win Nods; TCRX, NVS Cut Jobs; OVID, VIR Data; REGN, PASG Deals
Bank of New York Mellon Corp Makes New $8 Million Investment in Novavax, Inc. $NVAX
1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds
Novavax (NVAX) Could Be 34% Overvalued Following XFG Vaccine Approvals
Novavax Jumps 6% on Matrix-M Oncology Speculation: Is the Royalty Model the Real Story?
Novavax (NASDAQ:NVAX) Shares Up 5.3% - Here's What Happened - Stock Observer
Has Novavax (NVAX) Fallen Far Enough To Look Cheap?
FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech, Novavax - Update | Morningstar
Novavax partners secure Nuvaxovid approvals for 2026-2027 season
Novavax's XFG-Adapted Nuvaxovid Approved In U.S., EU, Japan For 2026-2027 Season
Novavax Partners Receive Approvals For Nuvaxovid Formulation To Target Covid Variant
Novavax's Partnership Strategy Continues to Deliver with XFG-adapted Nuvaxovid™ Approvals in the U.S., EU and Japan for 2026-2027 Vaccination Season | Morningstar
Zacks Research Has Negative Outlook for Novavax Q3 Earnings
Novavax Stock Pulls Back After Milestone Vaccine Success
Traders Purchase Large Volume of Put Options on Novavax (NASDAQ:NVAX)
Unpacking Q2 Earnings: Novavax (NASDAQ:NVAX) In The Context Of Other Therapeutics Stocks
Novavax (NASDAQ:NVAX) Trading Down 6.8% - Time to Sell? - Zolmax
NVAX Stock Alert: Biotechs Hit Post-Pandemic High on mRNA Cancer Breakthrough
Novavax (NASDAQ:NVAX) Trading Up 6.9% - Still a Buy?
Novavax (NASDAQ:NVAX) Shares Up 6.9% - Here's Why - Zolmax
Novavax (NASDAQ:NVAX) Stock Price Down 6.8% - What's Next?
Novavax (NVAX) Shares Skyrocket, What You Need To Know
Investors Buy Large Volume of Call Options on Novavax (NASDAQ:NVAX)
Traders Purchase Large Volume of Call Options on Novavax (NASDAQ:NVAX) - Stock Observer
